Pharmacists in Atwater, California


29 Pharmacists found in Atwater
male pharmacist

Matthew John Fagundes


Pharmacist
2730 Shaffer Rd, Atwater, CA 95301
209-357-9430     209-357-9595

male pharmacist

Michael Young, PHARMD


Pharmacist
1701 Bellevue Rd, Atwater, CA 95301
209-357-9840    

female pharmacist

Dr. Natalie Y Nickles, PHARM.D.


Pharmacist
1870 Bellevue Rd, Atwater, CA 95301
209-357-2956    



male pharmacist

Olubukola Sowunmi, PHARMD


Pharmacist
1651 Bellevue Rd, Atwater, CA 95301
209-358-3304    

male pharmacist

Rajvir Singh


Pharmacist
1651 Bellevue Rd, Atwater, CA 95301
209-358-3304    

male pharmacist

Dr. Ricardo Carrillo, PHARM.D.


Pharmacist
1713 Redwood Ave, Atwater, CA 95301
209-658-4137    

male pharmacist

Dr. Richard Adjetey Sewoatsri, PHARM. D


Pharmacist
2511 Boulder Dr, Atwater, CA 95301
415-652-5036    

female pharmacist

Dr. Sai Chia, PHARM D


Pharmacist
1651 Bellevue Rd, Atwater, CA 95301
209-358-3304     209-358-3793

female pharmacist

Sandeep Kaur Claire, PHARM D


Pharmacist
1701 Bellevue Rd, Atwater, CA 95301
209-357-2956     209-357-8172

male pharmacist

Sarbjit Singh Sahota


Pharmacist
1651 Bellevue Rd, Atwater, CA 95301
209-358-3304    

female pharmacist

Seema Saini, RPH


Pharmacist
1651 Bellevue Rd, Atwater, CA 95301
209-358-3304    

male pharmacist

Thomas Vang


Pharmacist
1701 Bellevue Rd, Atwater, CA 95301
209-357-2956    

male pharmacist

Xurachy Moua, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
800 Commerce Ave, Atwater, CA 95301
209-676-3117    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.